A detailed history of Headlands Technologies LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Headlands Technologies LLC holds 15,206 shares of TEVA stock, worth $258,197. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,206
Previous 3,461 339.35%
Holding current value
$258,197
Previous $36,000 494.44%
% of portfolio
0.05%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$10.67 - $14.43 $125,319 - $169,480
11,745 Added 339.35%
15,206 $214,000
Q4 2023

Feb 02, 2024

SELL
$8.12 - $10.63 $136,886 - $179,200
-16,858 Reduced 82.97%
3,461 $36,000
Q3 2023

Nov 09, 2023

SELL
$7.48 - $10.7 $50,886 - $72,792
-6,803 Reduced 25.08%
20,319 $207,000
Q2 2023

Aug 03, 2023

BUY
$7.2 - $9.47 $195,278 - $256,845
27,122 New
27,122 $204,000
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $2,178 - $2,597
274 New
274 $2,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.